GILDER GAGNON HOWE & CO LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 117 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$6,671,443
-18.2%
1,224,118
+0.7%
0.10%
-9.8%
Q2 2023$8,156,173
-21.0%
1,215,525
+3.9%
0.11%
-34.5%
Q1 2023$10,326,862
-61.0%
1,169,520
+24.1%
0.17%
+13.2%
Q4 2021$26,451,000
-60.5%
942,666
-52.1%
0.15%
-56.5%
Q3 2021$66,951,000
-20.1%
1,969,726
-3.9%
0.35%
-15.6%
Q2 2021$83,762,000
-12.7%
2,049,963
-14.0%
0.41%
-20.5%
Q1 2021$95,988,000
-31.6%
2,384,205
+0.4%
0.52%
-25.8%
Q4 2020$140,422,000
+20.5%
2,374,798
-0.9%
0.70%
-2.9%
Q3 2020$116,580,000
-1.9%
2,397,279
-2.4%
0.72%
-22.7%
Q2 2020$118,786,000
+87.6%
2,455,269
+7.7%
0.93%
+22.4%
Q1 2020$63,318,000
+169.5%
2,279,250
+190.3%
0.76%
+211.1%
Q4 2019$23,493,000
-4.1%
785,198
-0.9%
0.24%
-13.2%
Q3 2019$24,492,000
-14.3%
792,621
+33.9%
0.28%
-2.4%
Q2 2019$28,581,000591,7490.29%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2019
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$23,152,51615.55%
BERYLSON CAPITAL PARTNERS, LLC 289,726$2,213,5076.45%
Matrix Capital Management Company, LP 11,572,590$88,414,5881.69%
Pier Capital, LLC 1,012,401$7,734,7441.27%
VIKING GLOBAL INVESTORS LP 29,993,708$229,151,9291.15%
Eagle Health Investments LP 607,860$4,644,0501.07%
Triatomic Management LP 130,805$999,3500.84%
Aristotle Atlantic Partners, LLC 1,880,567$14,367,5320.80%
Senator Investment Group LP 1,000,000$7,640,0000.69%
ARK Investment Management 9,201,245$70,297,5120.61%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders